Status:
ACTIVE_NOT_RECRUITING
Engaging and Activating Cancer Survivors in Genetic Services Study
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
University of Pennsylvania
St. Jude Children's Research Hospital
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To address the gap in access to genetic services, this study will evaluate the effectiveness of an adapted model of remote delivery of genetic services to increase the uptake of recommended genetic as...
Detailed Description
As childhood cancer survivors receive care locally from PCPs, the in-home, collaborative PCP model is designed to increase access to genetic services and uptake of genetic testing in childhood cancer ...
Eligibility Criteria
Inclusion
- Able to understand and communicate in English or Spanish
- Currently residing in the US
- Childhood Cancer Survivor Study Participant survivors of the following primary cancers:
- CNS tumor
- Sarcoma (except Ewing sarcoma)
- Hepatoblastoma
- Leukemia
- Childhood Cancer Survivor Study Participant with a family history of a child with cancer:
- 2 or more malignancies in childhood (age 18 or younger)
- A first degree relative (parent or sibling) with cancer aged 45 or younger
- 2 or more second degree relatives with cancer aged 45 or younger (same side of family)
- Parents of the child with cancer are related (consanguinity)
- Other family history that meets NCCN criteria
- Able to communicate remotely through remote telegenetic platforms (phone or videoconference) with genetic counselors
Exclusion
- Uncorrected or uncompensated speech defects that would lead to the participant being unable to communicate effectively with genetic counselor
- Currently residing in a US state or territory where genetic counselors are not licensed to provide care
- Uncontrolled psychiatric/mental condition or severe physical, neurological or cognitive deficits rendering individual unable to understand study goals and task
- Participants who have already completed and received a clinically appropriate multi-gene panel genetic testing
Key Trial Info
Start Date :
August 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
391 Patients enrolled
Trial Details
Trial ID
NCT04455698
Start Date
August 16 2021
End Date
December 31 2025
Last Update
August 14 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago Medical Center
Chicago, Illinois, United States, 60637
2
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
3
St Jude Children's Research Hospital
Memphis, Tennessee, United States, 38105-3678